Clinical trial NCT00581672: Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Official title: Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Prostate Cancer
Keywords: Anxiety
Black men
Prostate Cancer
07-125
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
Collaborators: name: University School of Medicine(VA-NYU)
name: State University of New York - Downstate Medical Center
name: Kings County Hospital Center
First posted: 2007-12-28
Enrollment: 224
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Black men with prostate cancer

Brief summary: This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).


Eligibility criteria: Inclusion Criteria:

* 18 years of age or older
* Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
* Diagnosis of prostate cancer
* Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
* Ability to comprehend and complete questionnaires in English

Exclusion Criteria:

* Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
* Other non-Black or non-African-American ethnic groups

Primary outcomes:
measure: To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.
timeFrame: within one to three weeks of receiving their PSA scores from their physician
Secondary outcomes:
measure: To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.
timeFrame: within one to three weeks of receiving their PSA scores from their physician
Other outcomes:
Locations:
city: Brooklyn
country: United States
facility: Downstate Medical Center
state: New York
city: Brooklyn
country: United States
facility: Kings County Hopsital Center
state: New York
city: New York
country: United States
facility: Memorial Sloan Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: Christian Nelson, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Martin CM, Schofield E, Napolitano S, Avildsen IK, Emanu JC, Tutino R, Roth AJ, Nelson CJ. African-centered coping, resilience, and psychological distress in Black prostate cancer patients. Psychooncology. 2022 Apr;31(4):622-630. doi: 10.1002/pon.5847. Epub 2021 Nov 9.